{
    "SPADE_N_03153": {
        "Clinical Information": [],
        "Patent Information": [
            {
                "Patent No": "WO 2020/144166 A1",
                "Patent Link": "http://www.lens.org/lens/patent/WO_2020_144166_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2020-7-16",
                "Family Info": "/",
                "Patent Title": "Defensin Fragments For Use In Therapy Or Prophylaxis",
                "Abstract": "The present invention relates to new peptides derived from HD-5 or HNP-4 having antimicrobial activity for use in modulating the microbiome of intestines, the lungs, the skin, the mouth, the eye, the ear, the vagina or other bodily surfaces and/or for use as an antimicrobial agent in a human or other mammals, as well as to medicaments containing these peptides."
            }
        ],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_03153",
            "Peptide Name": "Human defensin-6 (HD-6; Defensin, alpha 6; Human, mammals, animals)",
            "Source": "Homo sapiens (Human)",
            "Family": "Belongs to the alpha-defensin family",
            "Gene": "DEFA6",
            "Sequence": "AFTCHCRRSCYSTEYSYGTCTVMGINHRFCCL",
            "Sequence Length": 32,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/Q01524"
            ],
            "Protein Existence": "Protein level",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal",
                "Antiviral(SARS-CoV-2)"
            ],
            "Target Organism": "[Ref.34206990]Virus:SARS-CoV-2:inhibition of infection in HEK293T-hACE2 cells(HD6 only blocked SARS-CoV-2 infection at the highest concentration tested (50 μg/mL, 13 μM)).Gram-negative bacteria:Escherichia coli ATCC 8739 (vLD50>256 µg/ml), E. coli ATCC 25922 (vLD50=103±14 µg/ml), Enterobacter aerogenes ATCC 13048 (vLD50=156±11 µg/ml);Gram-positive bacteria:Staphylococcus aureus ATCC 25923 (vLD50>256 µg/ml), S. aureus ATCC 29213 (vLD50>256 µg/ml), Bacillus cereus ATCC 10876 (vLD50=25±13 µg/ml).(Ref.3)NOTE:vLD50, virtual lethal doses (vLDs), equivalent to conventional 50% lethal doses (LD50s).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "[Ref.34206990]No cytotoxicity on HEK293T cells up to 50 μg/mL.",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Cyclic",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C156H234N46O46S7",
            "Mass": 3714.26,
            "PI": 8.35,
            "Net Charge": 4,
            "Hydrophobicity": -0.0,
            "Half Life": "Mammalian:4.4 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Has very low antimicrobial activity against Gram-negative and Gram-positive bacteria. May protect cells against infection with HIV-1.",
            "Subunit structure": "Homodimer.",
            "Tissue specificity": "Paneth cells of the small intestine.",
            "PTM": "Contains three disulfide bonds.",
            "Literature": [
                {
                    "Title": "Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.",
                    "Pubmed ID": "34206990",
                    "Reference": "Viruses. 2021 Jun 26;13(7)1246.",
                    "Author": "Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=34206990"
                },
                {
                    "Title": "Defensin-6 mRNA in human Paneth cells implications for antimicrobial peptides in host defense of the human bowel.",
                    "Pubmed ID": "8417977",
                    "Reference": "FEBS Lett. 1993; 315187-192.",
                    "Author": "Jones DE, Bevins CL.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=8417977"
                },
                {
                    "Title": "Crystal structures of human alpha-defensins HNP4, HD5, and HD6.",
                    "Pubmed ID": "17088326",
                    "Reference": "Protein Sci. 2006 Dec;15(12)2749-2760.",
                    "Author": "Szyk A, Wu Z, Tucker K, Yang D, Lu W, Lubkowski J.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=17088326"
                },
                {
                    "Title": "Antibacterial activity and specificity of the six human {alpha}-defensins.",
                    "Pubmed ID": "15616305",
                    "Reference": "Antimicrob Agents Chemother. 2005 Jan;49(1)269-275.",
                    "Author": "Ericksen B, Wu Z, Lu W, Lehrer RI.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15616305"
                },
                {
                    "Title": "Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel.",
                    "Pubmed ID": "",
                    "Author": "Bevins C.L.,Jones D.E."
                },
                {
                    "Title": "Human enteric defensins. Gene structure and developmental expression.",
                    "Pubmed ID": "",
                    "Author": "Deberardinis R.J.,Russell J.P.,Salzman N.,Harris A.,Mallow E.B."
                },
                {
                    "Title": "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).",
                    "Pubmed ID": "R2004J1449",
                    "Author": ""
                },
                {
                    "Title": "Antibacterial activity and specificity of the six human alpha-defensins.",
                    "Pubmed ID": "R2005J0141",
                    "Author": "Lehrer R.I.,Lu W.,Wu Z.,Ericksen B."
                }
            ],
            "Frequent Amino Acids": "CTR",
            "Absent Amino Acids": "DKOPQUW",
            "Basic Residues": 5,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 10,
            "Polar Residues": 24,
            "Positive Residues": 5,
            "Negative Residues": 1,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_02296",
                    "Similarity": 1.0,
                    "Sequence": "STRAFTCHCRRSCYSTEYSYGTCTVMGINHRFCCL"
                },
                {
                    "SPADE_ID": "SPADE_N_05927",
                    "Similarity": 1.0,
                    "Sequence": "AFTCHCRRSCYSTEYSYGTCTVMGINHRF"
                },
                {
                    "SPADE_ID": "SPADE_N_05928",
                    "Similarity": 1.0,
                    "Sequence": "AFTCHCRRSCYSTEYSYGTCTVMGINHR"
                }
            ]
        }
    }
}